|
DiapidDrug - Diapid The trade name of the product as shown on the labeling.
Dosage -
SOLUTION; NASAL
Active Ingredient(s) -
Lypressin
Strength -
0.185MG/ML
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
016755
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Novartis Pharmaceuticals Corp
Diapid
Loxitane Eq 10mg Base Capsule; Oral
Loxitane Eq 25mg Base Capsule; Oral Loxitane Eq 50mg Base Capsule; Oral Loxitane Eq 5mg Base Capsule; Oral Loxitane Eq 10mg Base Tablet; Oral Loxitane Eq 25mg Base Tablet; Oral Loxitane Eq 50mg Base Tablet; Oral Luveris 75 Iu/vial Injectable; Subcutaneous Diapid 0.185mg/ml Solution; Nasal Loxapine Succinate Eq 5mg Base Capsule; Oral NewDrugInformation |